Evotec SE
A life science company offering drug discovery and development partnership solutions.
EVT | F
Overview
Corporate Details
- ISIN(s):
- DE0005664809 (+1 more)
- LEI:
- 529900F9KI6OYITO9B12
- Country:
- Germany
- Address:
- Essener Bogen 7, 22419 Hamburg
- Website:
- https://www.evotec.com/en
Description
Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-11 13:55 | German | 12.2 KB | |||
| 2025-12-10 00:00 |
Company Presentation December 2025 (English)
|
English | 976.1 KB | ||
| 2025-12-09 10:40 |
Evotec SE: Prof. Dr. Iris Low-Friedrich, buy
|
English | 5.9 KB | ||
| 2025-12-08 07:00 |
Evotec closes sale of Just Evotec Biologics Toulouse site to Sandoz
|
English | 13.3 KB | ||
| 2025-12-04 08:30 |
Evotec-partner Bayer starts Phase 2 study for treatment of patients with Alport…
|
English | 14.3 KB | ||
| 2025-12-03 13:28 |
Release according to Article 41 of the WpHG [the German Securities Trading Act]…
|
English | 4.9 KB | ||
| 2025-11-28 11:23 | English | 16.6 KB | |||
| 2025-11-24 10:39 | English | 16.9 KB | |||
| 2025-11-17 15:27 |
Release of a capital market information
|
English | 8.2 KB | ||
| 2025-11-14 16:14 |
Evotec SE: Dr. Cord Dohrmann, sell
|
English | 6.1 KB | ||
| 2025-11-13 13:19 |
Evotec SE: Wesley Wheeler, buy
|
English | 6.0 KB | ||
| 2025-11-12 07:30 |
Evotec receives milestone payment from Bristol Myers Squibb following IND accep…
|
English | 14.5 KB | ||
| 2025-11-06 15:35 |
Release of a capital market information
|
English | 6.2 KB | ||
| 2025-11-06 00:00 |
Q3 statement / Q3 financial report 2025
|
English | 296.9 KB | ||
| 2025-11-05 07:30 |
Evotec SE reports 9M 2025 results: Continued strong execution on strategic prio…
|
English | 19.0 KB |
Automate Your Workflow. Get a real-time feed of all Evotec SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Evotec SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Evotec SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-06 | Dohrmann, Dr. Cord | Board | Other | None | 91,363.32 EUR |
| 2024-10-01 | Rouxel, Laetitia | Board | Other | None | 58,396.84 EUR |
| 2024-09-13 | Wojczewski, Dr. Christian | Board | Buy | None | 61,087.50 EUR |
| 2024-09-05 | Dalbiez, Aurélie | Board | Buy | None | 21,202.55 EUR |
| 2024-09-02 | Wojczewski, Dr. Christian | Board | Buy | None | 64,466.00 EUR |
| 2024-08-29 | Löw-Friedrich, Prof. Dr. Iris | Supervisory board | Buy | None | 100,050.00 EUR |
| 2024-08-23 | Wojczewski, Dr. Christian | Board | Buy | None | 113,291.94 EUR |
| 2024-08-22 | Johnstone, Dr. Craig | Board | Buy | None | 16,553.03 EUR |
| 2024-08-19 | Wojczewski, Dr. Christian | Board | Buy | None | 59,766.00 EUR |
| 2024-05-03 | Dohrmann, Dr. Cord | Board | Other | None | 76,220.10 EUR |
Peer Companies
